Update on Neuromodulation for Treatment-Resistant Depression [version 1; referees: 3 approved]
About 30% of patients suffering from a major depressive disorder do not respond sufficiently to established pharmacological, psychotherapeutic, or somatic treatments. Advances in technology and emerging knowledge about the dysfunctional brain circuits underlying depression have led to the developmen...
Main Authors: | Bettina Bewernick, Thomas E Schlaepfer |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2015-12-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/4-1389/v1 |
Similar Items
-
Metals and Neurodegeneration [version 1; referees: 3 approved]
by: Pan Chen, et al.
Published: (2016-03-01) -
Tourette syndrome research highlights 2015 [version 1; referees: 3 approved]
by: Cheryl A. Richards, et al.
Published: (2016-06-01) -
Chemotherapy-induced peripheral neuropathy: an update on the current understanding [version 1; referees: 2 approved]
by: James Addington, et al.
Published: (2016-06-01) -
Neuromodulation influences synchronization and intrinsic read-out [version 2; referees: 2 approved, 1 approved with reservations, 1 not approved]
by: Gabriele Scheler
Published: (2018-12-01) -
Updates in diabetic peripheral neuropathy [version 1; referees: 3 approved]
by: Kelsey Juster-Switlyk, et al.
Published: (2016-04-01)